Daily Archives: July 14, 2020

AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review

Thanks to ready access to hydrogen breath testing, small intestinal bacterial overgrowth is now commonly diagnosed among individuals presenting with a variety of gastrointestinal and even non-gastrointestinal complaints and is increasingly implicated, … Continue reading

Posted in News | Comments Off on AGA Clinical Practice Update on Small Intestinal Bacterial Overgrowth: Expert Review

Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease

The incidence of small bowel cancers is increasing. Associations have been made between celiac disease and small bowel cancers, but there have been no detailed studies of large cohorts. Continue reading

Posted in News | Comments Off on Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in a Nationwide Cohort of Individuals With Celiac Disease

Comparative Efficacy Trials in Inflammatory Bowel Disease

We may stumble and fall but shall rise again; it should be enough if we did not run away from the battle. Continue reading

Posted in News | Comments Off on Comparative Efficacy Trials in Inflammatory Bowel Disease

Assessment of evidence quality in IBD guidance: The use and misuse of GRADE

Posted in News | Comments Off on Assessment of evidence quality in IBD guidance: The use and misuse of GRADE

Insights from Pharmacovigilance: Gastrointestinal Related Immune Checkpoint Inhibitor Adverse Events

Posted in News | Comments Off on Insights from Pharmacovigilance: Gastrointestinal Related Immune Checkpoint Inhibitor Adverse Events

Postprandial chylomicron output and transport through intestinal lymphatics are not impaired in active Crohn’s disease

Posted in News | Comments Off on Postprandial chylomicron output and transport through intestinal lymphatics are not impaired in active Crohn’s disease

The Influence of Gut and Tumor Microbiome on Pancreatic Cancer Outcomes

Pancreatic cancer is a highly fatal malignancy with overall 5-year survival of under 10%, within the context of increasing incidence rates worldwide (Clin Gastroenterol Hepatol 2020 Mar 5. pii: S1542-3565(20)30276-7 [Epub ahead of print]). Even among t… Continue reading

Posted in News | Comments Off on The Influence of Gut and Tumor Microbiome on Pancreatic Cancer Outcomes